ATORVALIQ Trademark

Trademark Overview

On Monday, December 30, 2019, a trademark application was filed for ATORVALIQ with the United States Patent and Trademark Office. The USPTO has given the ATORVALIQ trademark a serial number of 88741769. The federal status of this trademark filing is REGISTERED as of Tuesday, September 19, 2023. This trademark is owned by CMP Pharma, Inc.. The ATORVALIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular disorders and cholesterol reduction
atorvaliq

General Information

Serial Number88741769
Word MarkATORVALIQ
Filing DateMonday, December 30, 2019
Status700 - REGISTERED
Status DateTuesday, September 19, 2023
Registration Number7169989
Registration DateTuesday, September 19, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 19, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular disorders and cholesterol reduction

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 6, 2020
Primary Code005
First Use Anywhere DateTuesday, June 20, 2023
First Use In Commerce DateTuesday, June 20, 2023

Trademark Owner History

Party NameCMP DEVELOPMENT LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressFARMVILLE, NC 27828
Party NameCMP DEVELOPMENT LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressFARMVILLE, NC 27828
Party NameCMP Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFarmville, NC 27828
Party NameCMP Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFarmville, NC 27828

Trademark Events

Event DateEvent Description
Tuesday, September 19, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 19, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, August 16, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 15, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, July 14, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 11, 2023USE AMENDMENT FILED
Tuesday, July 11, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, February 15, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, February 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 1, 2023SOU EXTENSION 5 GRANTED
Tuesday, January 17, 2023SOU EXTENSION 5 FILED
Wednesday, February 1, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 17, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, June 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 6, 2022SOU EXTENSION 4 GRANTED
Monday, June 6, 2022SOU EXTENSION 4 FILED
Monday, June 6, 2022SOU TEAS EXTENSION RECEIVED
Thursday, October 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 26, 2021SOU EXTENSION 3 GRANTED
Tuesday, October 26, 2021SOU EXTENSION 3 FILED
Tuesday, October 26, 2021SOU TEAS EXTENSION RECEIVED
Friday, February 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 10, 2021SOU EXTENSION 2 GRANTED
Wednesday, February 10, 2021SOU EXTENSION 2 FILED
Wednesday, February 10, 2021SOU TEAS EXTENSION RECEIVED
Friday, January 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 6, 2021SOU EXTENSION 1 GRANTED
Wednesday, January 6, 2021SOU EXTENSION 1 FILED
Wednesday, January 6, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, July 14, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 19, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 19, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 10, 2020ASSIGNED TO LIE
Thursday, April 2, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 24, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, March 24, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 24, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, March 24, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, March 23, 2020ASSIGNED TO EXAMINER
Monday, January 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 2, 2020NEW APPLICATION ENTERED

Related Keywords

atorvaliq cholesterol reduction disorders cardiovascular preparations treatment pharmaceutical